• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

How a DOGE review can actually improve the programs that fight HIV/AIDS

by April 28, 2025
written by April 28, 2025
NEWYou can now listen to Fox News articles!

President Donald Trump and Elon Musk’s Department of Government Efficiency have been aggressively overhauling the bloated and cumbersome U.S. federal bureaucracy by re-examining contracts, questioning what taxpayer dollars are funding and who that funding is going to. 

The public health sector hasn’t been immune, with the Trump administration poring over the layers of bureaucracy and freezing or canceling millions in grants. Countless programs within the Department of Health and Human Services (HHS), including those designed to target the treatment and spread of HIV/AIDS, are, or will be, in the crosshairs.

As a former White House director of national AIDS policy who was one of the chief architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), the first director of the HIV/AIDS Bureau at the Health Resources and Services Administration (HRSA), and as an LGBT conservative with a career in medicine, business, and public health, I believe HIV/AIDS advocates should embrace and support such a review. 

While it is critical that the United States’ demonstrably effective long-standing strategy tackling the HIV/AIDS epidemic, and the resources dedicated to it, remain intact, many of these federal programs have not been re-evaluated in years, nor have they been audited for waste, fraud or abuse. 

Advocates in support of maintaining the United States’ aggressive approach to the HIV/AIDS epidemic should welcome the review of HIV/AIDS specific initiatives to ensure that they are optimally designed to meet the needs of the current epidemic.

Take the Ryan White CARE Act, for example, which funds essential healthcare services for uninsured and underinsured individuals living with HIV/AIDS in the U.S. The program, which received $2.5 billion in federal funding in FY 2024, hasn’t been reauthorized by Congress since 2009. In that time, the expansion of healthcare coverage through Medicaid substantially reduced the number of people who needed Ryan White support for medical care and pharmaceuticals, yet its budget continued to grow. 

A reauthorization process would allow for a close look at spending priorities embedded in Ryan White – an initiative that was designed before highly effective HIV/AIDS therapy was even available. Surely, the HIV/AIDS community would do well to see if that funding might be better reallocated elsewhere, such as toward substance abuse and mental health services, or other needed care. 

DOGE can also remedy unnecessary bureaucratic overlap. The Ryan White program is run through the HRSA, and the Ending the HIV Epidemic initiative, started by Trump during his first term, is run through the Centers for Disease Control and Prevention (CDC). Despite the programs’ complementary missions, they are siloed off into separate entities with their own budgets and staff, resulting in unnecessary administrative overhead costs and potentially wasteful spending. 

The Trump administration is reportedly looking to streamline these two initiatives into one program run through the HRSA to consolidate the resources and make them more efficient. Advocates for a strong public health response to HIV/AIDS should be open to considering these kinds of commonsense reforms and not wringing their hands or fearmongering to voters.

While efficiency is needed, it would be a grave mistake to deprioritize funding for the HIV/AIDS epidemic as national policy. While new cases of the disease are on the decline in the U.S. due to advances in treatment and prevention efforts, data has shown that cutting those efforts leads to spikes in new infections, which in turn burden the healthcare system with costlier care and treatments down the line. 

Another critical pillar of the U.S. approach to the epidemic is PEPFAR, which funds HIV/AIDS prevention, treatment, and care globally. PEPFAR’s value is not only as a cost-effective success in saving millions of lives but also as a means of exerting significant diplomatic influence with dozens of partner nations. 

Secretary of State Marco Rubio granted PEPFAR a waiver from the initial suspension of global health initiatives in the first days of the Trump administration. That does not mean that PEPFAR should be immune from an audit for inefficiency. 

Like all federal programs, there must be improvements that can be made and waste that can be cut. PEPFAR’s strategy and tactics, however, are undeniably working with an incredible return on investment. Keeping the program efficiently funded should be a bipartisan priority.

It’s easy to panic over reports of specific cuts or reorganizations to HIV/AIDS programs. Opponents of the Trump administration have every reason to fearmonger around the issue, as federal funding for prevention efforts is generally popular. 

But, if we genuinely care about the fight against HIV/AIDS, we must recognize that these programs, like the federal government itself, are not perfect. These HIV/AIDS programs are long overdue for auditing, evaluation and perhaps reorganization, and as long as our commitment to fighting the disease remains intact, the United States’ efforts will be stronger for it.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Greenland’s prime minister says island cannot be bought, US has ‘not been respectful’
next post
SCOOP: Dept of Energy says it saved $700M in Trump’s first 100 days by cutting ‘wasteful’ programs

related articles

Trump DOJ to begin handing over Epstein files...

August 22, 2025

TikTok isn’t enough to stop Gen Z from...

August 22, 2025

Trump administration wins Supreme Court fight to slash...

August 22, 2025

Zelenskyy seeks ‘strong reaction’ from US if Putin...

August 22, 2025

Pentagon unveils new medal for troops deployed in...

August 21, 2025

Federal judge rules Trump appointee Alina Habba is...

August 21, 2025

‘Maine’s Mamdani’: Maine GOP chief issues warning about...

August 21, 2025

‘There are 50 swamps’: State Freedom Caucus Network...

August 21, 2025

Trump-aligned legal group probes Biden-era organ transplant program...

August 21, 2025

NATO defense chiefs stress commitment to Ukraine, discuss...

August 21, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Davos 2025: Collaborative Solutions for a Divided World

    January 24, 2025
  • Gaza protesters plague Harris rallies: ‘Wish I Could Vote For U’

    October 31, 2024
  • Newsom calls Trump’s claims ‘pure fiction’ after president-elect points finger over California fire tragedy

    January 9, 2025
  • ‘Would love to’: Republicans jostle for open spots on Marjorie Taylor Greene-led DOGE panel

    November 21, 2024
  • Pete Hegseth confirmed to lead Pentagon after VP Vance casts tie-breaking vote

    January 25, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,785)
  • Investing (634)
  • Stock (893)

Latest Posts

  • Biden ‘Politburo’ member Steve Ricchetti to appear before House investigators in Comer cover-up probe

    July 30, 2025
  • Senate parliamentarian: Who is the unelected official getting say on Trump’s ‘big, beautiful bill?’

    May 12, 2025
  • Nifty and German 40: Nifty rises to a new all-time high

    August 29, 2024

Recent Posts

  • CFD Modelling: Learn About Derivative Trading

    July 23, 2024
  • ‘Moana 2’ tops $1 billion, extending Disney’s box office domination

    January 22, 2025
  • The price of natural gas is rising ahead of the coming storm

    September 11, 2024

Editor’s Pick

  • President Trump can stop Iran’s march to nuclear weapons: ‘re-establish credible military threat’, report says

    February 19, 2025
  • Dozens of female Trump staffers, surrogates blast Mark Cuban as ‘misogynistic’ in new campaign ad

    November 1, 2024
  • Boeing says it’s progressing on safety reforms and working with DOJ on revised plea deal

    April 3, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock